First Horizon Advisors’s AMAG Pharmaceuticals AMAG Stock Holding History

First Horizon Advisors’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-111	Closed	-$2K	–	1439
2016 Q1	$2K	Buy	111 +105	+1,750%	+$2.49K	﹤0.01%	1265
2015 Q4	$0	Sell	6 -182	-97%	-$5.88K	﹤0.01%	1412
2015 Q3	$7K	Hold	188	–	–	﹤0.01%	1098
2015 Q2	$12K	Buy	+188	New	+$11.8K	﹤0.01%	987
2014 Q1	–	Sell	-1	Closed	–	–	1527
2013 Q4	$0	Buy	+1	New	+$24	﹤0.01%	1440

Other funds holding AMAG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SIM

Stelliam Investment Management New York $404M AUM 5.1% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

First Horizon Advisors's AMAG Position: Q2 2016 in Review

First Horizon Advisors sold out of AMAG Pharmaceuticals (AMAG) in Q2 2016, closing a stake of 111 shares — an estimated $2K sold.

First Horizon Advisors first reported a position in AMAG in Q4 2013 and held it in 5 quarters. The position peaked at $12K in Q2 2015. 165 funds tracked by Wall St. Rank hold AMAG as of Q2 2016.

First Horizon Advisors reported no remaining AMAG Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
First Horizon Advisors sold 111 AMAG Pharmaceuticals shares in Q2 2016, an estimated $2K.
First Horizon Advisors first reported a position in AMAG Pharmaceuticals in Q4 2013 and held it in 5 quarters.
First Horizon Advisors's AMAG Pharmaceuticals position peaked at $12K in Q2 2015.
165 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2016.

Based on First Horizon Advisors's 13F filing for Q2 2016, filed 29 Jul 2016.